As of June 30, 2024, 2cureX AB carries a market capitalization of 781,569.47, placing it among publicly traded companies globally. Its enterprise value stands at 506,015.83, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 781,569.47 |
| Enterprise Value | 506,015.83 |
As of June 30, 2024, 2cureX AB has 17.60M shares outstanding.
| Shares Outstanding | 17.60M |
These figures are as of June 30, 2024.
| PB Ratio | 3.19 |
| P/TBV Ratio | 3.19 |
As of June 30, 2024, 2cureX AB maintains a current ratio of 1.51, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.51 |
| Quick Ratio | 0.73 |
These figures cover the twelve months ended June 30, 2024.
| Employee Count | 9.00 |
As of the close on August 31, 2026, 2cureX AB's stock has declined approximately 79.25% over the past 52 weeks. The 50-day moving average sits at 0.14, while the 200-day moving average is 0.14.
| 52-Week Price Change | -79.25% |
| 50-Day Moving Average | 0.14 |
| 200-Day Moving Average | 0.14 |
These figures are as of June 30, 2024. Total book value stands at 245,259.47, with working capital of 191,716.29 providing operational flexibility.
| Cash & Cash Equivalents | 275,553.64 |
| Net Debt | -275,553.64 |
| Equity (Book Value) | 245,259.47 |
| Book Value Per Share | 0.01 |
| Working Capital | 191,716.29 |
2cureX AB's most recent stock split took place on May 2, 2019 with a 789:835 split ratio.
| Last Split Date | 5/2/2019 |
| Split Ratio | 789:835 |
Already premium?